REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $130,691,120 | +2.9% | 4,721,500 | -0.5% | 2.11% | +16.3% |
Q2 2023 | $126,955,500 | +23.5% | 4,746,000 | -0.0% | 1.81% | +21.4% |
Q1 2023 | $102,839,514 | -11.1% | 4,747,900 | -2.2% | 1.49% | -2.8% |
Q4 2022 | $115,649,959 | +25.3% | 4,855,162 | +3.7% | 1.54% | +15.8% |
Q3 2022 | $92,293,000 | +40.0% | 4,680,162 | +38.3% | 1.32% | +42.2% |
Q2 2022 | $65,940,000 | -21.9% | 3,383,262 | +2.2% | 0.93% | -5.0% |
Q1 2022 | $84,455,000 | -3.3% | 3,310,662 | -4.6% | 0.98% | +9.0% |
Q4 2021 | $87,344,000 | -8.2% | 3,470,162 | +0.3% | 0.90% | -6.8% |
Q3 2021 | $95,152,000 | +61.6% | 3,458,805 | +86.5% | 0.97% | +68.0% |
Q2 2021 | $58,871,000 | +20.4% | 1,854,805 | +74.0% | 0.58% | +11.2% |
Q1 2021 | $48,897,000 | +2986.9% | 1,065,770 | +2564.4% | 0.52% | +2772.2% |
Q4 2020 | $1,584,000 | – | 40,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |